Oroxylin A
Catalog No. A14367
Oroxylin A是一种O-甲基化的黄酮,具有多巴胺再摄取抑制剂的活性,并且是GABAA受体的苯二氮卓部位的负变构调节剂。
- Paramesha Bugga, .et al. Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast, Cell Signal, 2022, Jun;94:110309 PMID: 35304284
- Bugga Paramesha, .et al. Sirt1 and Sirt3 Activation Improved Cardiac Function of Diabetic Rats via Modulation of Mitochondrial Function, Antioxidants (Basel), 2021, Feb 24;10(3):338 PMID: 33668369
- Mai Nagasaka, .et al. Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway, Molecules, 2018, Jun; 23(6): 1394 PMID: 29890668
Catalog Num | A14367 |
---|---|
M. Wt | 284.27 |
Formula | C16H12O5 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 480-11-5 |
Synonyms | Oroxyline-A, OroxylinA |
SMILES | COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)O |
Oroxylin A是一种O-甲基化的黄酮,具有多巴胺再摄取抑制剂的活性,并且是GABAA受体的苯二氮卓部位的负变构调节剂。
In vitro | DMSO | 53 mg/mL (186.44 mM) | |
Water | |||
Ethanol | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 35.18 mL | 175.89 mL | 351.78 mL |
0.5 mM | 7.04 mL | 35.18 mL | 70.36 mL |
1 mM | 3.52 mL | 17.59 mL | 35.18 mL |
5 mM | 0.7 mL | 3.52 mL | 7.04 mL |
*The above data is based on the productmolecular weight 284.27. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.